About TINKESO THERAPEUTICS INC
Tinkeso Therapeutics is an early-stage biotech company based in Valhalla, NY, focused on developing novel off-the-shelf, allogeneic Natural Killer T (NKT) cell therapies for the treatment of cancers and other immune-mediated disorders. The company's lead asset is IMK-101, an engineered invariant NKT (iNKT) cell therapy targeting several types of leukemia.
Is this your company?
Claim TINKESO THERAPEUTICS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim TINKESO THERAPEUTICS INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.